Molecular Diagnostics
Screening Portfolio Protects Patients from Cervical Cancer and Overtreatment
A new portfolio of clinically validated genetic and pathology tests for human papillomavirus cervical cancer screening and diagnosis helps identify women at high risk of developing this highly preventable disease, which is nevertheless still classified as the 4th most frequent cancer in women—530,000 new cases annually, of which about half the patients die. More...20 Oct 2015
![Image: A new test can detect virtually any virus that infects people and animals, including the Ebolavirus depicted in this enhanced electron micrograph (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2015-10-14/GMS-353.jpg "Image: A new test can detect virtually any virus that infects people and animals, including the Ebolavirus depicted in this enhanced electron micrograph (Photo courtesy of the [US] National Institute of Allergy and Infectious Diseases).")
New Target Sequence Capture Panel Eases Detection of Viruses in Patient Samples
A recently developed targeted sequence capture panel, ViroCap, which was designed to enrich nucleic acid from DNA and RNA viruses that infect vertebrate hosts, allowed the rapid detection of unknown viruses in patient samples. More...14 Oct 2015
![Image: Photomicrograph of a band-form trophozoite of P. malariae in a thin blood smear (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2015-10-07/RLJ-324.jpg "Image: Photomicrograph of a band-form trophozoite of P. malariae in a thin blood smear (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention).")
DNA Alterations Identified Occur Earliest in Lung Cancer Development
Lungs resected for adenocarcinomas often harbor minute discrete foci of cytologically atypical pneumocyte proliferations designated as atypical adenomatous hyperplasia, which may represent an initial step in the progression to adenocarcinoma in situ. More...30 Sep 2015
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Urine Analyzer
respons® UDS100
New
Steam Sterilizer
Hi Vac II Line
In Other News
New Virus Identified in Blood Supply
Micro Ribonucleic Nucleic Acid Panel Assays Launched
Pancreatic Cancer Tumor and Stroma Subtypes Discovered
Gene Signature Predicts Alzheimer's Disease
Testicular Cancer Risk Comes from Inherited Genetic Faults
Biomarker Helps Predict Stomach Cancer Survival
Independent Prognostic Biomarker Found for Klatskin Tumor Patients
Custom-Designed SNP Array Facilitates Japanese Genomic Studies
Relapse In Leukemia Linked to Genetic Mutations
Blood Test Developed to Catch Pancreatic Cancer Early
Liquid Biopsy Assay Predicts Risk of Breast Cancer Relapse
Mutated Group B Streptococcus Causes Neonatal Sepsis
Gene Sequencing Reference Standard Increases Accuracy for Medical Laboratories
Globally Accurate Diagnostic Test Developed for Herpes
Padlock Probe Assay Rapidly Detects Cardiac Disease Gene Mutations
Biomarker Identified in Breast and Prostate Cancers
Biomarker Tied to Poor Survival for Colorectal Cancer Patients
Microscopy and Molecular Assay Compared for Schistosomiasis Diagnosis
HPV16 in Oral Rinses Predicts Prognosis in Oropharyngeal Cancer
Blood Markers Identify Women at Risk for Postpartum Depression
Molecular Assay for MERS CoV Receives Emergency Use Authorization
CE Marking of Theranostic Monitoring Test Announced at 2015 AACC Annual Meeting
Low Cost Point-of-Care DNA Amplification Test for Chlamydia Infection Demonstrated at the 2015 AACC Annual Meeting
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.